The Importance of Randomization in Tumor MAB

I think maybe their thought process wasn't that complicated though. I think it was really, if we don't not randomize patients, they're going to take them off study. Because right when you have this drug, and not only are hematologists wanting to use it, but also the train,. transpliners in the room are now demanding that your patients be MRD negative before you take them to transplant. So I think it became really complicated to keep the randomization there from a logistical standpoint.